Calantha is the first RNA based foliar insecticide to be granted EPA approval. It is incredible to be part of such an innovative, talented and driven team. Stay tuned for more exciting news from GreenLight Biosciences in 2024!!
https://t.co/bz9oRFpcOi
GreenLight Biosciences starts a new chapter today as a listed public benefit corporation $GRNA.
We harness the power of biology to meet the needs of the human race.🧵
RNA innovation for agriculture goes underground!! Exploring the the next generation of RNA based products through a partnership with a leader in the seed treatment industry.
https://t.co/3720o26onm
Producing amounts of RNA thought impossible now at our Rochester production facility.
GreenLight is making the impossible, possible for RNA technology. Congrats to the team in Rochester and others across GreenLight that made this possible.
https://t.co/Y4J9PNTDiM
Thanks to the team at GreenLight Biosciences that made this possible. We could not have achieved this milestone without the technology, the scientist who developed it and those who are turning the technology into products for Human Health and Agriculture. Congrats to all!
WSJ News Exclusive from @AmrithRamkumar: GreenLight Biosciences, a developer of mRNA vaccines to fight Covid-19 and other diseases, is going public via a $1.5 billion SPAC merger https://t.co/kPBo7DVGAi via @WSJ
I’m proud to announce on World Bee Day that GreenLight BioSciences is working to support bee health by developing RNA technology to protect bees from Varroa mite. GreenLight continues to lead in RNA technology development. #WorldBeeDay#WorldBeeDay2021
https://t.co/w1xG3uoJo4
My past and future collide through the development of RNA based products for Ag. Thank you and congratulations to all my past colleagues at Monsanto and Bayer for the hard work to develop and launch SmartStax Pro.
https://t.co/pFyJMh0QWf
Engaging the worlds top scientists to build foundational knowledge for RNA to protect crops, protect bees and support biodiversity through a collaboration between Fraunhofer IME (Germany) and GreenLight.
https://t.co/FRCjSmXHKE
GreenLight Biosciences is looking for a Senior Scientist with a history of deploying creative solutions to solve complex problems in the RNA field. Come join our team of innovative scientist focused on developing RNA based products at GreenLight. https://t.co/O3DHZKa04C
Another step on the journey towards making RNA based products a reality for the benefit of agriculture and human health. Proud to be part of the innovative team of scientists and leaders who support GreenLight Biosciences!
We've raised $102M round of funding from new & existing #investors including Morningside, @seed2growth, @rwbaird, and @LACAgriFood to rapidly develop and commercialize sustainable solutions for #agriculture & #lifesciences applications: https://t.co/EFrueOaaOw
Another milestone towards helping to make RNA vaccines cost effective, fighting the pandemic that is "the COVID" and preparing for the future. Thanks to all who support GreenLight's RNA innovation platform in plant and animal sciences
https://t.co/x0Ew0IcTCD
The Colorado Potato Beetle #biocontrol solution we are developing is effective at low use rates, making it a cleaner, more #sustainable alternative to traditional #pesticides.
For those of you looking for fun for the kids during this extended break, the Boston Museum of Science is transitioning to digital platform during coronavirus outbreak.
https://t.co/5IRVd6SMcN
We’re all moved in to the new office in RTP, North Carolina! Excited to contribute to the culture of innovation here and meet our neighbors. https://t.co/UoKLXDWgOJ
USDA WASDE Report for 2019/20 – January Update indicates that both corn and soybean global stocks are forecast down after a tough production year globally. Additionally, China’s soybean crush estimate increased by 0.5 MT. Hopefully a signal for better commodity prices to come!
New weed control solutions needed quickly. France’s health and safety regulator ANSES has withdrawn the marketing licence for 36 products containing glyphosate, including several versions of Bayer’s Roundup, which accounted for ~3/4th of the GLY products sold last year in France